Delivery Order SPE2DB20D1047-SPE2DB23FF57M
Award Date
4/13/23
Potential Completion Date
4/14/23
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GARDASIL 9 syringes to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a firm fixed price and a ceiling value of $6,370.51, with a period of performance ending on May 6, 2024. The contract is a delivery order and is not associated with a set-aside designation, indicating open competition....
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 mL) to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which specializes in pharmaceutical distribution and healthcare solutions. The award has a ceiling value of $9,111.57 and an ultimate completion date of October 19, 2023. This is a delivery order contract with a firm fixed-price pricing type. The contract is not...
This federal contract award is for the delivery of GARDASIL 9 vaccine syringes to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $8,792.15 delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and an ultimate completion date of January 26, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent...
The federal contract award is for the delivery of GARDASIL 9 syringes (0.5ML) to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,194.36 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 1, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award is for the delivery of GARDASIL 9 SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., both of which are for-profit organizations registered in the System for Award Management (SAM.gov). The contract, valued at $7,338.62, is a delivery order with a firm fixed price and a completion date of August 5,...
The federal contract award is for the delivery of GARDASIL 9 vaccine syringes to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price of $77,936.83 and an ultimate completion date of May 20, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and...
This federal contract award is for the delivery of GARDASIL 9 syringes to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $64,414.45 and is a firm fixed-price delivery order with an ultimate completion date of April 22, 2024. It is not a set-aside contract....
This federal contract award is for the delivery of GARDASIL 9 syringes to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a total ceiling value of $2,344.67 and an ultimate completion date of December 6, 2023. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated with any set-aside requirements,...
This federal contract award is for the delivery of GARDASIL 9 syringes, 0.5 ml each, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,107.19 and an ultimate completion date of May 3, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 mL) to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price of $7,886.65 and an ultimate completion date of April 21, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...